CEO and Co-Founder, Eascra Biotech
Mari Anne Snow is the CEO and co-founder of Eascra Biotech, a nanomedicine startup located in Boston, MA that specializes in targeted therapeutic delivery of nucleotides and other medicinal cargos into hard-to-penetrate tissues like articular cartilage, kidneys, and solid tumors. Eascra is the first commercial company to produce its non-lipid-based Janus base nanoparticles (JBNps) in space for medical applications on Earth. In collaboration with NASA, the ISS National Lab, Axiom Space and a host of commercial space partners, Mari Anne and her team are utilizing low earth orbit to accelerate product development and drive rapid market entry. The Eascra team has sent five payloads to the ISS over the past two years and is currently planning their sixth mission scheduled for the spring of 2026.